Company / Operating Income per Share
Beam Therapeutics Inc. Operating Income per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.77
FY2025
5-year range
-$5.74 / -$2.16
FY2021-FY2025
Trend
+24.1%
vs FY2024
Sector context
#155 of 201
Health Care
What the data says
Beam Therapeutics Inc.'s operating income per share of $-3.77 is lower than 77% of companies in the Health Care sector (FY2025). Declined from $-2.16 to $-3.77 over the past 2 years.
Based on SEC 10-K filings.
-3.77 in FY2025.
Declined from $-2.16 to $-3.77 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 201This company -$3.77 Sector average -$28.56
▼
+86.8% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 24.1% year-over-year.
- Ranks #155 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2023.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.77 | +24.1% |
| FY2024 | -$4.97 | -129.8% |
| FY2023 | -$2.16 | +54.5% |
| FY2022 | -$4.75 | +17.2% |
| FY2021 | -$5.74 | +44.1% |
| FY2020 | -$10.26 | +11.6% |
| FY2019 | -$11.60 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026